Kaempferol inhibits the proliferation and migration of RA-FLSs and the release of activated T-cell-mediated inflammatory cytokines by suppressing fibroblast growth factor receptor 3-ribosomal S6 kinase 2 (FGFR3-RSK2) signaling34. The gene discussed is FGFR3; the disease is rheumatoid arthritis.